Carl Zeiss Meditec AG

48
Sell
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE0005313704
EUR
24.32
-0.68 (-2.72%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
No of Months
12
12
12
12
12
12
Operating Income
2,227.00
2,066.00
2,089.00
1,902.00
1,646.00
1,335.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
2,227.00
2,066.00
2,089.00
1,902.00
1,646.00
1,335.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
674.00
616.00
527.00
437.00
378.00
352.00
Operating Expenses
26.00
29.00
15.00
9.00
8.00
27.00
General and Administration Expenses
592.00
514.00
493.00
429.00
356.00
342.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
1,970.00
1,835.00
1,726.00
1,496.00
1,268.00
1,151.00
Operating Profit (PBDIT) excl Other Income
256.00
230.00
362.00
406.00
378.00
183.00
Other Income
-17.00
61.00
76.00
14.00
-23.00
28.00
Operating Profit (PBDIT)
366.00
425.00
513.00
490.00
416.00
272.00
Interest
26.00
29.00
15.00
9.00
8.00
27.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
126.00
132.00
74.00
69.00
61.00
60.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
193.00
243.00
413.00
403.00
339.00
178.00
Provision for Tax
51.00
60.00
120.00
107.00
101.00
55.00
Profit After Tax
141.00
178.00
290.00
293.00
236.00
122.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
1.61
2.01
3.25
3.29
2.64
1.37
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Sep 2025 is 7.82% vs -1.11% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Sep 2025 is 11.30% vs -36.42% in Sep 2024

stock-summary

Interest

YoY Growth in year ended Sep 2025 is -9.60% vs 92.94% in Sep 2024

stock-summary

Profit After Tax

YoY Growth in year ended Sep 2025 is -20.99% vs -38.45% in Sep 2024

Compare Profit and Loss Results of Carl Zeiss Meditec AG
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
No of Months
12
12
Operating Income
2,227.00
22,873.00
-20,646.00
-90.26%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
2,227.00
22,873.00
-20,646.00
-90.26%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
674.00
10,099.00
-9,425.00
-93.33%
Operating Expenses
26.00
438.00
-412.00
-94.06%
General and Administration Expenses
592.00
2,882.00
-2,290.00
-79.46%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,970.00
20,695.00
-18,725.00
-90.48%
Operating Profit (PBDIT) excl Other Income
256.00
2,178.00
-1,922.00
-88.25%
Other Income
-17.00
293.00
-310.00
-105.80%
Operating Profit (PBDIT)
366.00
3,591.00
-3,225.00
-89.81%
Interest
26.00
438.00
-412.00
-94.06%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
126.00
1,120.00
-994.00
-88.75%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
193.00
1,990.00
-1,797.00
-90.30%
Provision for Tax
51.00
582.00
-531.00
-91.24%
Profit After Tax
141.00
1,536.00
-1,395.00
-90.82%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.6132
2.2442
-0.63
-28.12%
Profit And Loss - Net Sales
Net Sales 2,227.64 Million
in Sep 2025

Figures in Million
stock-summary

YoY Growth in year ended Sep 2025 is 7.82% vs -1.11% in Sep 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 256.80 Million
in Sep 2025

Figures in Million
stock-summary

YoY Growth in year ended Sep 2025 is 11.30% vs -36.42% in Sep 2024

Profit And Loss - Interest
Interest 26.60 Million
in Sep 2025

Figures in Million
stock-summary

YoY Growth in year ended Sep 2025 is -9.60% vs 92.94% in Sep 2024

Profit And Loss - Profit After Tax
Profit After Tax 141.21 Million
in Sep 2025

Figures in Million
stock-summary

YoY Growth in year ended Sep 2025 is -20.99% vs -38.45% in Sep 2024